Home : October 2011 : October 31, 2011 News : Oxford BioMedica Announces Research and Development Collaboration for Glaucoma

Oxford BioMedica Announces Research and Development Collaboration for Glaucoma

October 31, 2011

OXFORD, England, October 31, 2011 /PRNewswire/ -- - Research and development agreement signed with Mayo Clinic - Oxford BioMedica plc ("Oxford BioMedica" or "the Company") (LSE: OXB), the leading gene-based biopharmaceutical company, today announces that it has entered into a...

http://www.prnewswire.com/news-releases/oxford-biomedica-announces-research-and-development-collaboration-for-glaucoma-132903598.html
Other Stories